Stakeholders: The main stakeholders in this case would be the patients who took Vioxx. They are interested parties in the market because they undertake a transaction to purchase Vioxx. Patients have both economic and legal power. Economic power because they can choose whether or not to enter into an economic transaction with the company and legal power because they can sue the company for damages. Patients can form coalitions with lawyers and sue Merck in class actions. This would make the process faster because it would not be individual cases but just one case. The FDA is a market stakeholder because it has entered into an economic transaction with Merck. Merck had to pay “use fees” to the FDA to review Vioxx. The FDA has economic power because it can deny testing of new drugs created by Merck. They also have legal and political power because they have the ability to sue with the help of the Department of Justice and create new regulations. Coalitions that the FDA may form may include plaintiffs and lawyers discussing strategies to defeat Merck in the court of